S 4390 117th Congress Senate Health

Accelerated Approval Transparency Act

Introduced: June 14, 2022 Introduced by: Hickenlooper, John W. Democratic · Colorado See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jun 14, 2022

Introduced in Senate

Jun 14, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Accelerated Approval Transparency Act

This bill requires the Food and Drug Administration to include a summary of the reasons a drug or biologic received accelerated approval to treat a serious or life-threatening disease or condition in the public action package for the drug or biologic.

What's happening now June 14, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Bill text 1 version

Introduced in Senate Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 1

Health, Education, Labor, and Pensions Committee
Senate

Cite this page click to expand

APA

U.S. Congress. (2026). S. 4390: Accelerated Approval Transparency Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-4390/

MLA

"S. 4390: Accelerated Approval Transparency Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-4390/.

Bluebook (legal)

S. 4390, 117th Cong. (2026), https://openamerica.io/bill/117-S-4390/.

Markdown link

[S. 4390: Accelerated Approval Transparency Act](https://openamerica.io/bill/117-S-4390/)